Share
Peripheral Intravenous Catheters Market Size, Share, and Analysis, By Product Type (Short PIVC, Integrated/Closed PIVC), By Technology (Conventional PIVC, Safety PIVC), By End User (Hospitals, Ambulatory Surgical Centres, and Other End Users) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
Peripheral Intravenous Catheters Market is expected to expand at a CAGR of 6.8% from 2024 to 2034. Valued at USD 5.2 billion in 2023, the market is projected to reach USD 10.8 billion by 2034.
Peripheral intravenous catheters (PIVCs) are small, flexible tubes inserted into peripheral veins to provide intravenous access for administering fluids, medications, and drawing blood. They are extensively used in hospitals, clinics, and home care settings for short-term treatments. PIVCs are available in various types, including short peripheral catheters, midline catheters, and specialty catheters, made from materials like polyurethane and PVC. While essential for patient care, PIVCs can lead to complications such as infections and blood clots. Technological advancements in catheter design and materials aim to improve safety and patient comfort. The rising elderly population, the prevalence of chronic diseases, and enhancements in healthcare facilities drive the increasing demand for PIVCs.
Peripheral Intravenous Catheters is expected to reach $10.8 billion, with a growth rate of 6.8% due to various strong reasons. The increasing prevalence of chronic illnesses such as diabetes and cardiovascular diseases necessitates regular intravenous treatments, fueling market demand. Additionally, the aging population requires more frequent medical interventions, further driving market growth. Technological improvements in catheter design and materials, aimed at enhancing patient safety and comfort, are also contributing to the market's expansion. Enhanced healthcare infrastructure and a rising number of hospital admissions further support market growth. The market is expected to continue growing, driven by ongoing innovations and increased healthcare access in developing regions.
Source: Fatpos Global
Short Peripheral Intravenous Catheters (PIVCs) have secured a leading position in the market due to their cost-effectiveness and ease of use. These catheters are commonly utilized for short-term applications such as administering medications, providing fluids, and drawing blood. They are particularly popular in outpatient settings, emergency departments, and during minor surgeries. Their affordability, combined with the simplicity of insertion and removal, has solidified their strong presence in the market. Short PIVCs are favored by healthcare facilities that prioritize budget-conscious options while ensuring efficient patient care.
Peripheral Intravenous Catheters Market is classified based on Technology into Conventional PIVC, and Safety PIVC. Safety Peripheral Intravenous Safety Peripheral Intravenous Catheters (PIVCs) dominate the market due to their focus on enhanced patient safety and compliance with regulatory requirements. These safety PIVCs feature built-in mechanisms that automatically retract the needle after use, significantly reducing the risk of needle stick injuries and infections. Regulatory mandates in many countries requiring the use of safety devices have further driven the adoption of safety PIVCs. Although safety PIVCs may have a higher initial cost, their overall benefits, including reduced healthcare expenses from fewer needle stick injuries and infections, outweigh the initial investment. The industry's increasing emphasis on patient safety and healthcare worker protection has accelerated the shift toward using safer medical devices, such as safety PIVCs.
Growing Emphasis on Patient Safety is Propelling the Adoption of PIVCs’
The growing emphasis on patient safety is a significant driver of the increased adoption of peripheral intravenous catheters (PIVCs), particularly those with safety-enhanced features. Traditional PIVCs pose a risk of needle stick injuries to healthcare providers, potentially leading to infections and the transmission of bloodborne diseases. Safety-enhanced PIVCs are designed with features such as automatic needle retraction, which reduce these risks and improve overall safety. Many countries now have regulations that mandate the use of safety devices, further promoting their widespread adoption. Additionally, hospitals and clinics are recognizing the long-term financial benefits of using safety PIVCs, as they reduce costs associated with treating needle stick injuries and related infections. The increasing focus on both patient and healthcare worker safety is a critical factor driving the broad adoption of safety PIVCs in medical settings.
Rising Geriatric Population Leads to Increased PIVC Usage
The rising geriatric population is also a key factor contributing to the increased use of peripheral intravenous catheters (PIVCs). Older adults are more susceptible to chronic illnesses and health conditions that require regular medical treatments such as hydration, medication administration, and blood tests. This demographic shift results in a growing demand for PIVCs to effectively address their healthcare needs. Furthermore, elderly individuals often have more complex medical conditions, necessitating frequent hospital visits and treatments that involve IV access. As the global population ages, healthcare systems are under increasing pressure to accommodate this expanding demographic, leading to a surge in PIVC usage. Consequently, the growing healthcare needs of the aging population play a major role in driving the growth and expansion of the PIVC market.
Risk of Complications Associated with Peripheral Intravenous Catheters May Restrict Market Growth
The risk of complications associated with peripheral intravenous catheters (PIVCs) may limit market growth. Complications such as infections, thrombosis, and phlebitis are significant concerns when using PIVCs. Infections can occur if the catheter site is not properly sterilized, or if the catheter is left in place for too long, putting the patient at risk of severe health issues. Thrombosis, or the formation of blood clots around the catheter, can lead to discomfort and inflammation, potentially necessitating catheter removal. Phlebitis, the inflammation of a blood vessel, may occur due to mechanical or chemical irritation from the infusion fluid. These risks can lead to increased medical costs, extended hospital stays, and the need for additional medical interventions, causing healthcare providers and patients to be cautious when considering PIVC use, despite its benefits.
Peripheral Intravenous Catheters Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a strong presence in the peripheral intravenous catheters (PIVCs) market due to various reasons. The region boasts a sophisticated healthcare system that guarantees broad access to and utilization of advanced medical equipment such as PIVCs. Furthermore, the participation of dominant industry leaders, along with strong research and development efforts, promotes innovation and acceptance of new products. Regulatory requirements that emphasize patient safety and the utilization of safety-engineered devices also contribute to the growth of the market. Moreover, increased healthcare expenses and insurance availability support the use of more expensive yet safer PIVCs, strengthening North America's market leadership.
Source: Fatpos Global
The COVID-19 pandemic had a multifaceted impact on the Peripheral Intravenous Catheters Market. The outbreak resulted in a rise in the need for PIVCs due to more people being hospitalized and requiring intravenous treatments in critical care units. Patients experiencing severe symptoms of COVID-19 frequently need significant IV therapy for fluids, medications, and blood tests, increasing the use of PIVCs. In addition, the increased emphasis on infection control during the pandemic emphasized the significance of safety-engineered PIVCs, which reduced the chances of needle stick injuries and infections. This resulted in a quicker uptake of safety PIVCs in healthcare environments. Nevertheless, the presence of PIVCs was initially limited due to supply chain disruptions and manufacturing difficulties caused by the pandemic. In the face of these difficulties, the healthcare market experienced growth as healthcare systems adjusted to the rising demand and put a focus on ensuring the safety of patients and healthcare workers.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2034 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2034 |
|
Historical Period |
2019-2022 |
|
Growth Rate |
CAGR of 6.8% from 2024-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
By Product |
|
|
By Technology |
|
|
By End User |
|
|
By Region |
|
Peripheral Intravenous Catheters Market size was valued at USD 5.2 billion in 2023 and is projected to reach the value of USD 10.8 billion in 2034, exhibiting a CAGR of 6.8% during the forecast period
Peripheral Intravenous Catheters (PIVC) market encompasses the production and sale of flexible tubes inserted into veins for administering fluids, medications, or drawing blood. It's a crucial segment of the medical device industry, driven by increasing healthcare procedures and patient care advancements.
The Short PIVC and Safety PIVC segment accounted for the largest Peripheral Intravenous Catheters Market share.
Key players in the Peripheral Intravenous Catheters Market include Becton, Dickinson and Company (BD), Medtronic, Baxter International, Smiths Medical (ICU Medical), Terumo Corporation, Telefex Incorporated, Fresenius Medical Care, Cardinal Health, Cook Medical, Braun Melsungen AG, Vygon, Arrow International, CareFusion, Merit Medical Systems, Sorenson Medical and Other Prominent Players.
Rising chronic diseases, an aging population, technological advancements, and increasing focus on patient safety drive the Peripheral Intravenous Catheters market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
